1274 related articles for article (PubMed ID: 29175242)
1. Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients.
Lee YH; Kim KJ; Yoo ME; Kim G; Yoon HJ; Jo K; Youn JC; Yun M; Park JY; Shim CY; Lee BW; Kang SM; Ha JW; Cha BS; Kang ES
J Hepatol; 2018 Apr; 68(4):764-772. PubMed ID: 29175242
[TBL] [Abstract][Full Text] [Related]
2. Nonalcoholic fatty liver disease, diastolic dysfunction, and impaired myocardial glucose uptake in patients with type 2 diabetes.
Lee M; Kim KJ; Chung TH; Bae J; Lee YH; Lee BW; Cha BS; Yun M; Kang ES
Diabetes Obes Metab; 2021 Apr; 23(4):1041-1051. PubMed ID: 33394549
[TBL] [Abstract][Full Text] [Related]
3. Association between non-alcoholic fatty liver disease and myocardial glucose uptake measured by
Tang K; Zheng X; Lin J; Zheng M; Lin H; Li T; Wang L
J Nucl Cardiol; 2020 Oct; 27(5):1679-1688. PubMed ID: 30238301
[TBL] [Abstract][Full Text] [Related]
4. Hepatic steatosis is associated with abnormal hepatic enzymes, visceral adiposity, altered myocardial glucose uptake measured by
Hu L; Shao X; Qiu C; Shao X; Wang X; Niu R; Wang Y
BMC Endocr Disord; 2020 May; 20(1):75. PubMed ID: 32460891
[TBL] [Abstract][Full Text] [Related]
5. Association between Non-Alcoholic Steatohepatitis and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus.
Lee H; Kim G; Choi YJ; Huh BW; Lee BW; Kang ES; Cha BS; Lee EJ; Lee YH; Huh KB
Diabetes Metab J; 2020 Apr; 44(2):267-276. PubMed ID: 30877708
[TBL] [Abstract][Full Text] [Related]
6. Non-alcoholic fatty liver disease with reduced myocardial FDG uptake is associated with coronary atherosclerosis.
Tang K; Lin J; Ji X; Lin T; Sun D; Zheng X; Wang L
J Nucl Cardiol; 2021 Apr; 28(2):610-620. PubMed ID: 31077075
[TBL] [Abstract][Full Text] [Related]
7. Nonalcoholic fatty liver disease and advanced fibrosis are associated with left ventricular diastolic dysfunction.
Chung GE; Lee JH; Lee H; Kim MK; Yim JY; Choi SY; Kim YJ; Yoon JH; Kim D
Atherosclerosis; 2018 May; 272():137-144. PubMed ID: 29604480
[TBL] [Abstract][Full Text] [Related]
8. Relation of Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease to Left Ventricular Diastolic Function and Exercise Tolerance.
Canada JM; Abbate A; Collen R; Billingsley H; Buckley LF; Carbone S; Trankle CR; Idowu MO; Kadariya D; Van Tassell B; Sanyal AJ; Siddiqui MS
Am J Cardiol; 2019 Feb; 123(3):466-473. PubMed ID: 30502049
[TBL] [Abstract][Full Text] [Related]
9. Epicardial fat, cardiac geometry and cardiac function in patients with non-alcoholic fatty liver disease: association with the severity of liver disease.
Petta S; Argano C; Colomba D; Cammà C; Di Marco V; Cabibi D; Tuttolomondo A; Marchesini G; Pinto A; Licata G; Craxì A
J Hepatol; 2015 Apr; 62(4):928-33. PubMed ID: 25445395
[TBL] [Abstract][Full Text] [Related]
10. Serum cytokeratin-18 and its relation to liver fibrosis and steatosis diagnosed by FibroScan and controlled attenuation parameter in nonalcoholic fatty liver disease and hepatitis C virus patients.
Darweesh SK; AbdElAziz RA; Abd-ElFatah DS; AbdElazim NA; Fathi SA; Attia D; AbdAllah M
Eur J Gastroenterol Hepatol; 2019 May; 31(5):633-641. PubMed ID: 30839434
[TBL] [Abstract][Full Text] [Related]
11. Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: A population-based study.
VanWagner LB; Wilcox JE; Colangelo LA; Lloyd-Jones DM; Carr JJ; Lima JA; Lewis CE; Rinella ME; Shah SJ
Hepatology; 2015 Sep; 62(3):773-83. PubMed ID: 25914296
[TBL] [Abstract][Full Text] [Related]
12. Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients.
Garg H; Aggarwal S; Shalimar ; Yadav R; Datta Gupta S; Agarwal L; Agarwal S
Surg Obes Relat Dis; 2018 Jan; 14(1):81-91. PubMed ID: 29126863
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal Association of Non-Alcoholic Fatty Liver Disease With Changes in Myocardial Structure and Function: The CARDIA Study.
VanWagner LB; Wilcox JE; Ning H; Lewis CE; Carr JJ; Rinella ME; Shah SJ; Lima JAC; Lloyd-Jones DM
J Am Heart Assoc; 2020 Feb; 9(4):e014279. PubMed ID: 32067588
[TBL] [Abstract][Full Text] [Related]
14. Association of the Non-Alcoholic Fatty Liver Disease Fibrosis Score with subclinical myocardial remodeling in patients with type 2 diabetes: A cross-sectional study in China.
Fan N; Ding X; Zhen Q; Gu L; Zhang A; Shen T; Wang Y; Peng Y
J Diabetes Investig; 2021 Jun; 12(6):1035-1041. PubMed ID: 33030804
[TBL] [Abstract][Full Text] [Related]
15. MEASUREMENT OF CONTROLLED ATTENUATION PARAMETER: A SURROGATE MARKER OF HEPATIC STEATOSIS IN PATIENTS OF NONALCOHOLIC FATTY LIVER DISEASE ON LIFESTYLE MODIFICATION - A PROSPECTIVE FOLLOW-UP STUDY.
Paul J; Venugopal RV; Peter L; Shetty KNK; Shetti MP
Arq Gastroenterol; 2018; 55(1):7-13. PubMed ID: 29561981
[TBL] [Abstract][Full Text] [Related]
16. Activating transcription factor 3 is a target molecule linking hepatic steatosis to impaired glucose homeostasis.
Kim JY; Park KJ; Hwang JY; Kim GH; Lee D; Lee YJ; Song EH; Yoo MG; Kim BJ; Suh YH; Roh GS; Gao B; Kim W; Kim WH
J Hepatol; 2017 Aug; 67(2):349-359. PubMed ID: 28365312
[TBL] [Abstract][Full Text] [Related]
17. Genetic Variants in nicotinamide-N-methyltransferase (NNMT) gene are related to the stage of non-alcoholic fatty liver disease diagnosed by controlled attenuation parameter (CAP)-fibroscan.
Hasan EM; Abd Al Aziz RA; Sabry D; Darweesh SK; Badary HA; Elsharkawy A; Abouelkhair MM; Yosry A
J Gastrointestin Liver Dis; 2018 Sep; 27(3):265-272. PubMed ID: 30240470
[TBL] [Abstract][Full Text] [Related]
18. Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
Eddowes PJ; Sasso M; Allison M; Tsochatzis E; Anstee QM; Sheridan D; Guha IN; Cobbold JF; Deeks JJ; Paradis V; Bedossa P; Newsome PN
Gastroenterology; 2019 May; 156(6):1717-1730. PubMed ID: 30689971
[TBL] [Abstract][Full Text] [Related]
19. Hepatic artery resistive index (HARI) and non-alcoholic fatty liver disease (NAFLD) fibrosis score in NAFLD patients: cut-off suggestive of non-alcoholic steatohepatitis (NASH) evolution.
Tana C; Tana M; Rossi S; Silingardi M; Schiavone C
J Ultrasound; 2016 Sep; 19(3):183-9. PubMed ID: 27635163
[TBL] [Abstract][Full Text] [Related]
20. The triglyceride-glucose index is associated with the severity of hepatic steatosis and the presence of liver fibrosis in non-alcoholic fatty liver disease: a cross-sectional study in Chinese adults.
Guo W; Lu J; Qin P; Li X; Zhu W; Wu J; Xu N; Zhang Q
Lipids Health Dis; 2020 Oct; 19(1):218. PubMed ID: 33028338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
